Meeting
2021 Gastrointestinal Cancers Symposium
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable esophagogastric junction adenocarcinoma: A retrospective study.
Authors
Toshiharu Hirose
Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
Toshiharu Hirose , Shun Yamamoto , Kotoe Oshima , Hidekazu Hirano , Natsuko Okita Tsuda , Hirokazu Shoji , Satoru Iwasa , Yoshitaka Honma , Atsuo Takashima , Narikazu Boku , Zyunya Oguma , Koshiro Ishiyama , Hiroyuki Daiko , Ken Kato
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Esophageal and Gastric Cancer
Track
Esophageal and Gastric Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 209)
DOI
10.1200/JCO.2021.39.3_suppl.209
Abstract #
209
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
First Author: Yuri Yoshinami
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Docetaxel-based triplet neoadjuvant therapy for esophageal adenocarcinoma: A comprehensive analysis of outcomes spanning over a decade.
First Author: James Tankel
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Efficacy of prophylactic pegfilgrastim on day three of preoperative DCF chemotherapy in elderly patients with resectable esophageal cancer.
First Author: Go Ikeda
Poster
2024 ASCO Gastrointestinal Cancers Symposium
FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF, FLOT therapy for locally advanced esophageal carcinoma (JCOG1804E)—Primary safety and short-term efficacy results for cohort E.
First Author: Takako Yoshii